Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073) is a clinical research site located in Mineola, New York, United States 11501.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Triple Negative Breast Neoplasms.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073) has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Neoplasms.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.